Logo image of OPRA

OPERA LTD-ADR (OPRA) Stock Fundamental Analysis

USA - NASDAQ:OPRA - US68373M1071 - ADR

16.1768 USD
+0.07 (+0.41%)
Last: 10/20/2025, 3:41:56 PM
Fundamental Rating

7

OPRA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. OPRA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. OPRA is growing strongly while it also seems undervalued. This is an interesting combination This makes OPRA very considerable for value and growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

OPRA had positive earnings in the past year.
In the past year OPRA had a positive cash flow from operations.
Of the past 5 years OPRA 4 years were profitable.
Each year in the past 5 years OPRA had a positive operating cash flow.
OPRA Yearly Net Income VS EBIT VS OCF VS FCFOPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of OPRA (7.53%) is better than 81.05% of its industry peers.
With a decent Return On Equity value of 8.43%, OPRA is doing good in the industry, outperforming 72.98% of the companies in the same industry.
The Return On Invested Capital of OPRA (8.38%) is better than 80.35% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OPRA is significantly below the industry average of 11.90%.
The last Return On Invested Capital (8.38%) for OPRA is above the 3 year average (6.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.53%
ROE 8.43%
ROIC 8.38%
ROA(3y)8.12%
ROA(5y)7.3%
ROE(3y)8.98%
ROE(5y)7.94%
ROIC(3y)6.4%
ROIC(5y)N/A
OPRA Yearly ROA, ROE, ROICOPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

With a decent Profit Margin value of 14.51%, OPRA is doing good in the industry, outperforming 78.60% of the companies in the same industry.
In the last couple of years the Profit Margin of OPRA has declined.
OPRA has a better Operating Margin (16.45%) than 82.81% of its industry peers.
OPRA's Gross Margin of 67.16% is in line compared to the rest of the industry. OPRA outperforms 47.72% of its industry peers.
In the last couple of years the Gross Margin of OPRA has declined.
Industry RankSector Rank
OM 16.45%
PM (TTM) 14.51%
GM 67.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-12.55%
GM growth 3Y-8.45%
GM growth 5Y-5.94%
OPRA Yearly Profit, Operating, Gross MarginsOPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OPRA is destroying value.
The number of shares outstanding for OPRA has been increased compared to 1 year ago.
The number of shares outstanding for OPRA has been reduced compared to 5 years ago.
Compared to 1 year ago, OPRA has an improved debt to assets ratio.
OPRA Yearly Shares OutstandingOPRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OPRA Yearly Total Debt VS Total AssetsOPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

OPRA has an Altman-Z score of 9.32. This indicates that OPRA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.32, OPRA belongs to the best of the industry, outperforming 84.91% of the companies in the same industry.
OPRA has a debt to FCF ratio of 0.09. This is a very positive value and a sign of high solvency as it would only need 0.09 years to pay back of all of its debts.
The Debt to FCF ratio of OPRA (0.09) is better than 82.11% of its industry peers.
OPRA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
OPRA has a Debt to Equity ratio of 0.01. This is in the better half of the industry: OPRA outperforms 67.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.09
Altman-Z 9.32
ROIC/WACC0.91
WACC9.2%
OPRA Yearly LT Debt VS Equity VS FCFOPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

OPRA has a Current Ratio of 2.43. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.43, OPRA is in the better half of the industry, outperforming 69.82% of the companies in the same industry.
OPRA has a Quick Ratio of 2.43. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
OPRA has a Quick ratio of 2.43. This is in the better half of the industry: OPRA outperforms 69.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.43
OPRA Yearly Current Assets VS Current LiabilitesOPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

The earnings per share for OPRA have decreased strongly by -47.55% in the last year.
The Earnings Per Share has been growing by 29.22% on average over the past years. This is a very strong growth
The Revenue has grown by 29.39% in the past year. This is a very strong growth!
The Revenue has been growing by 22.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-47.55%
EPS 3Y189.45%
EPS 5Y29.22%
EPS Q2Q%8.33%
Revenue 1Y (TTM)29.39%
Revenue growth 3Y24.3%
Revenue growth 5Y22.22%
Sales Q2Q%30.28%

3.2 Future

The Earnings Per Share is expected to grow by 17.17% on average over the next years. This is quite good.
The Revenue is expected to grow by 14.66% on average over the next years. This is quite good.
EPS Next Y30.94%
EPS Next 2Y27.71%
EPS Next 3Y26.67%
EPS Next 5Y17.17%
Revenue Next Year25.94%
Revenue Next 2Y20.2%
Revenue Next 3Y18.17%
Revenue Next 5Y14.66%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OPRA Yearly Revenue VS EstimatesOPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
OPRA Yearly EPS VS EstimatesOPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.5 1 1.5 2 2.5

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.12, OPRA is valued correctly.
Based on the Price/Earnings ratio, OPRA is valued cheaply inside the industry as 84.21% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.42. OPRA is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 10.23, the valuation of OPRA can be described as very reasonable.
Based on the Price/Forward Earnings ratio, OPRA is valued cheaper than 89.82% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. OPRA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.12
Fwd PE 10.23
OPRA Price Earnings VS Forward Price EarningsOPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

OPRA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OPRA is cheaper than 87.72% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OPRA is valued cheaper than 89.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.09
EV/EBITDA 12.1
OPRA Per share dataOPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

OPRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OPRA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as OPRA's earnings are expected to grow with 26.67% in the coming years.
PEG (NY)0.49
PEG (5Y)0.52
EPS Next 2Y27.71%
EPS Next 3Y26.67%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.76%, OPRA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 36.72, OPRA pays a better dividend. On top of this OPRA pays more dividend than 98.25% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, OPRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.76%

5.2 History

OPRA has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
OPRA Yearly Dividends per shareOPRA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

78.12% of the earnings are spent on dividend by OPRA. This is not a sustainable payout ratio.
DP78.12%
EPS Next 2Y27.71%
EPS Next 3Y26.67%
OPRA Yearly Income VS Free CF VS DividendOPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
OPRA Dividend Payout.OPRA Dividend Payout, showing the Payout Ratio.OPRA Dividend Payout.PayoutRetained Earnings

OPERA LTD-ADR

NASDAQ:OPRA (10/20/2025, 3:41:56 PM)

16.1768

+0.07 (+0.41%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-19 2025-08-19/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners16.7%
Inst Owner Change-1.78%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.45B
Analysts83.08
Price Target26.01 (60.79%)
Short Float %6.19%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield 4.76%
Yearly Dividend0.43
Dividend Growth(5Y)N/A
DP78.12%
Div Incr Years0
Div Non Decr Years0
Ex-Date07-08 2025-07-08 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.41%
Min EPS beat(2)-1.96%
Max EPS beat(2)8.78%
EPS beat(4)2
Avg EPS beat(4)1.28%
Min EPS beat(4)-3.68%
Max EPS beat(4)8.78%
EPS beat(8)5
Avg EPS beat(8)62.49%
EPS beat(12)7
Avg EPS beat(12)47.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.79%
Min Revenue beat(2)1.07%
Max Revenue beat(2)6.51%
Revenue beat(4)4
Avg Revenue beat(4)2.9%
Min Revenue beat(4)0.3%
Max Revenue beat(4)6.51%
Revenue beat(8)5
Avg Revenue beat(8)1.27%
Revenue beat(12)9
Avg Revenue beat(12)1.56%
Revenue beat(16)13
Avg Revenue beat(16)2.05%
PT rev (1m)0%
PT rev (3m)-1.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.29%
EPS NY rev (1m)12.18%
EPS NY rev (3m)5.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.27%
Valuation
Industry RankSector Rank
PE 15.12
Fwd PE 10.23
P/S 2.61
P/FCF 14.09
P/OCF 13.71
P/B 1.52
P/tB 3.39
EV/EBITDA 12.1
EPS(TTM)1.07
EY6.61%
EPS(NY)1.58
Fwd EY9.78%
FCF(TTM)1.15
FCFY7.1%
OCF(TTM)1.18
OCFY7.29%
SpS6.21
BVpS10.68
TBVpS4.77
PEG (NY)0.49
PEG (5Y)0.52
Profitability
Industry RankSector Rank
ROA 7.53%
ROE 8.43%
ROCE 9.43%
ROIC 8.38%
ROICexc 9.73%
ROICexgc 26.48%
OM 16.45%
PM (TTM) 14.51%
GM 67.16%
FCFM 18.5%
ROA(3y)8.12%
ROA(5y)7.3%
ROE(3y)8.98%
ROE(5y)7.94%
ROIC(3y)6.4%
ROIC(5y)N/A
ROICexc(3y)7.3%
ROICexc(5y)N/A
ROICexgc(3y)20.62%
ROICexgc(5y)N/A
ROCE(3y)7.2%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-12.55%
GM growth 3Y-8.45%
GM growth 5Y-5.94%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.09
Debt/EBITDA 0.05
Cap/Depr 16.3%
Cap/Sales 0.52%
Interest Coverage 161.16
Cash Conversion 96.93%
Profit Quality 127.49%
Current Ratio 2.43
Quick Ratio 2.43
Altman-Z 9.32
F-Score5
WACC9.2%
ROIC/WACC0.91
Cap/Depr(3y)62.94%
Cap/Depr(5y)43.53%
Cap/Sales(3y)2.11%
Cap/Sales(5y)1.89%
Profit Quality(3y)170.05%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.55%
EPS 3Y189.45%
EPS 5Y29.22%
EPS Q2Q%8.33%
EPS Next Y30.94%
EPS Next 2Y27.71%
EPS Next 3Y26.67%
EPS Next 5Y17.17%
Revenue 1Y (TTM)29.39%
Revenue growth 3Y24.3%
Revenue growth 5Y22.22%
Sales Q2Q%30.28%
Revenue Next Year25.94%
Revenue Next 2Y20.2%
Revenue Next 3Y18.17%
Revenue Next 5Y14.66%
EBIT growth 1Y15.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.98%
EBIT Next 3Y28.9%
EBIT Next 5Y21.17%
FCF growth 1Y25.75%
FCF growth 3Y47.38%
FCF growth 5YN/A
OCF growth 1Y27.54%
OCF growth 3Y58.11%
OCF growth 5YN/A